Notification of Transactions of Directors, Persons Discharging Managerial
Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares purchased at a price of £11.22 per share, and Ordinary share ADRs purchased at a price of $33.85 per ADR in GlaxoSmithKline plc on 15 October 2008, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 9 October 2008.
|
Ordinary shares |
ADRs |
Mr A P Witty |
229.89 |
|
Mr J S Heslop |
46.28 |
|
Dr M M Slaoui |
67.34 |
|
Mrs C E Bruck Slaoui |
20.94 |
|
Mr S M Bicknell |
29.93 |
|
Mr J M Clarke |
142.93 |
|
Mr M Dunoyer |
86.58 |
|
Mr E J Gray |
86.89 |
|
Mr D Learmouth |
52.09 |
|
Mr W C Louv |
|
55.88 |
Mr D J Phelan |
|
170.58 |
Dr D Pulman |
|
98.68 |
Mr D S Redfern |
0.39 |
|
Ms C Thomas |
65.37 |
|
Mr J R Stéphenne |
242.27 |
|
The Company was advised of this information on 20 October 2008.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
20 October 2008